CME Topics

Cardiology & Family Medicine

CME AWAY® by Sea Courses is pleased to invite you to a 10-Night CME Cruise to Hawaii in September 2026.   Dr. Peter Lin and Dr. Andrew Ignaszewski have developed an interactive educational program that will be of interest to family physicians, specialists, and allied health professionals.   Dr. Peter Lin is a Family Physician from Toronto, Canada. He is the Director of Primary Care Initiatives at the Canadian Heart Research Centre.  He was also a contributing author to the Canadian Diabetes Guidelines 2013 and 2018 on the vascular protection section.   He has worked with KDIGO in an effort to help improve care for chronic kidney disease patients. He has also been tracking and providing information on COVID-19 to the public since the beginning of the pandemic. Dr. Lin continues to be a medical correspondent at CBC (Canadian Broadcasting Corporation).   Dr. Lin’s Topics for this CME program will include COPD , Drug Interactions, Vaccines, Chronic Kidney Disease, AI in Medical Practice and Microplastics.   Dr. Andrew Ignaszewski is the Physician-in Chief Department of Medicine, Providence Health Care Vancouver BC. He was the Founding Medical Director of Heart Function Clinic, St. Paul’s Hospital and is a Professor of Medicine (Cardiology) at the University of British Columbia. He has published 77 papers and 128 abstracts.   Dr. Ignaszewski is also involved in the teaching of medical students and medical residents at St. Paul’s Hospital. He has received teaching awards from the University of British Columbia such as Best Teacher during a clinical rotation, Excellence in Clinical Teaching Skills and Teacher of the Year Awards.   For this program, his topics will include Atrial Fibrillation, Congestive Heart Failure, Hypertension, Diabetes, Obesity and Cardiac Imaging.   Dr. Lin and Dr. Ignaszewski are very much looking forward to seeing you on this Cruise in Hawaii.  

Dr. Andrew Ignaszewski

  1)Atrial Fibrillation  - what is new for 2026 and beyond

• Examine the update on stroke prevention strategies
• Discuss who  needs AF ablation?

  2) Congestive Heart Failure , now that we have  HFrEF, HFmrEF and HFpEF how do we treat them?

• Cite what is new in HFrEF?
• Cite what is new in HfpEF?

  3) Preventive Cardiology in 2026 - focus on new therapies for lipid lowering

• Review the use of  Icosapent ethyl
• Evaluate who  needs injectable meds?

  4) Hypertension 2026 – what’s on the horizon?

• Review what is still important?
• Examine  new data is coming to help us manage it

  5) Diabetes and Obesity Treatments from Cardiology Point of View

• Review available treatment options for diabetes and obesity
• Cite  the evidence for the reduction in CV events/mortality

  6) A Cardiologists approach to chest pain

• Discuss Non-invasive evaluation – who needs angiogram
• Evaluate Medical therapy for chest pain vs. PCI

  7) Imaging of the heart disease

• Explore what to order and when?
• Discuss how to interpret the tests?

  8) Cardiology Potpourri

• Discuss very thing you ever wanted to ask
• Review participant cases

 

Dr. Lin

  1)Huffing and Puffing - COPD - Gold guidelines

• Cite the new COPD Guidelines – both the GOLD and Canadian guidelines to our COPD patients
• Examine the importance of mortality benefits for our patients

    2) SGLT2i, GLP1-RA, Finerenone in CKD Patients

• Explain how SGLT2 inhibitors, GLP1 and Finerenone are defining new pillars for patients with CKD.
• SGLT2i can be used in diabetes and non diabetic CKD.

    3) Vaccines - Shingles, RSV, Flu and Covid

• Identify patients that need these vaccines
• Explain the vaccinations and their benefits

  4) Drug Interactions - A primer for all physicians

• Explore a framework to think about drug interactions
• Explain how to actively help patients avoid these drug interactions

  5) My On-Line rating indicates that I am a bad doctor?

• Examine how we can deteriorate over time as we get busier
• Explain how  to avoid these pitfalls

  6)Microplastics – A New CV Risk Factor?

• Be able to describe microplastics and its effects on the body especially as a CV risk factor
• Help patients reduce their exposure to microplastics

  7) AI - The Good, The Bad, and The Ugly (Navigating the New Reality of AI in Medicine)

• Describe how AI is changing the way we practice medicine
• Explore the potential pitfalls based on how AI was trained and will be trained
• Illustrate how to use AI and get the benefits while minimizing the potential harm